April 24 (Reuters) - Oriola Oyj OKDBV.HE :
* Q1 NET SALES EUR 459.8 MILLION VERSUS EUR 397.1 MILLION YEAR AGO
* Q1 ADJUSTED OPERATING PROFIT EUR 6.9 MILLION VERSUS EUR 3.7 MILLION YEAR AGO
* ORIOLA - COVID-19 PANDEMIC CAUSED A PEAK IN DEMAND FOR PHARMACEUTICALS AND RAPIDLY CHANGED
OPERATING ENVIRONMENT.
* ORIOLA - 2020 ADJUSTED EBIT ON A CONSTANT CURRENCY BASIS IS ESTIMATED TO INCREASE FROM
2019
LEVEL.
* ORIOLA - RESTRICTIONS ON CITIZENS' MOBILITY, AND BURDEN ON PUBLIC HEALTHCARE CAPACITY
CAUSED BY
PANDEMIC INEVITABLY ALSO IMPACT ORIOLA'S BUSINESS.
Source text for Eikon: ID:nWkr1kLWhB
Further company coverage: OKDBV.HE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))